Section: Pet Bacteria

Feline Respiratory Infections: Etiology, Clinical Signs, Zoonotic Risk, and Prevention

Feline respiratory infections (FRI) represent a complex clinical syndrome involving multiple viral and bacterial pathogens that colonize the upper and lower respiratory tracts of domestic cats. These infections are among the most common reasons for veterinary consultation worldwide and impose significant morbidity in multi-cat environments such as shelters, breeding catteries, and boarding facilities [1, 2]. Understanding the etiological agents, transmission dynamics, clinical manifestations, zoonotic potential, and preventive measures is essential for effective clinical management and public health protection.

Etiology: Primary and Secondary Pathogens

Feline respiratory infections are typically polymicrobial, with primary viral agents often predisposing cats to secondary bacterial invasion [2, 3]. The major viral pathogens are feline herpesvirus type 1 (FHV 1) and feline calicivirus (FCV), which together account for approximately 80 to 90 percent of all FRI cases [1, 4]. Among bacteria, Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma felis are the most frequently isolated secondary or primary bacterial agents [3, 5].

Viral Agents

Feline herpesvirus 1 (FHV 1) is an enveloped, double-stranded DNA virus of the family Herpesviridae, subfamily Alphaherpesvirinae [1]. The virus exhibits tropism for the conjunctival and respiratory epithelium, establishing lifelong latency in the trigeminal ganglia after primary infection [2, 4]. Reactivation occurs during periods of stress, immunosuppression, or corticosteroid administration, leading to recurrent clinical signs and intermittent viral shedding [1, 4].

Feline calicivirus (FCV) is a non-enveloped, single-stranded RNA virus of the family Caliciviridae [2]. Multiple antigenic strains exist, with variable virulence ranging from mild oral ulceration to severe systemic disease characterized by edema, cutaneous ulcers, and hepatic necrosis (virulent systemic FCV) [2, 4]. FCV replicates in the oral and respiratory mucosa and is shed in oral secretions, ocular discharge, and fomites [1, 3].

Bacterial Agents

Bordetella bronchiseptica is a Gram-negative, aerobic coccobacillus that colonizes the ciliated respiratory epithelium [3, 5]. The organism produces several virulence factors including tracheal cytotoxin, adenylate cyclase toxin, and filamentous hemagglutinin, which impair mucociliary clearance and facilitate adherence to host cells [3, 6]. B. bronchiseptica is considered a primary pathogen in kittens and immunocompromised adults, and it can also act as a secondary invader following viral damage to the respiratory epithelium [5, 6].

Chlamydia felis is an obligate intracellular Gram-negative bacterium that primarily infects conjunctival epithelial cells [3, 5]. The pathogen is transmitted via direct contact with ocular or nasal discharges and is a common cause of persistent conjunctivitis in multi-cat households [3, 5]. Coinfection with FHV 1 or FCV is frequently observed [3, 5].

Mycoplasma felis is a cell wall deficient bacterium that colonizes the upper respiratory tract and conjunctiva [3, 6]. M. felis is often isolated from cats with chronic conjunctivitis and upper respiratory signs, although its exact pathogenic role remains debated due to its presence in healthy carriers [3, 6].

Pathogen Type Primary Site Secondary Invader
FHV 1 DNA virus Conjunctiva, nasal epithelium Yes (facilitates bacterial infection)
FCV RNA virus Oral mucosa, respiratory tract Yes (facilitates bacterial infection)
B. bronchiseptica Gram-negative bacterium Ciliated respiratory epithelium Yes (often secondary)
C. felis Intracellular bacterium Conjunctival epithelium Yes (often secondary)
M. felis Cell wall deficient bacterium Conjunctiva, upper respiratory tract Yes (often secondary)

Transmission: How Do Cats Get Respiratory Infections?

Understanding how cats get respiratory infections requires examination of the primary routes of pathogen dissemination. Direct contact is the most efficient mode of transmission for all major feline respiratory pathogens [1, 2]. Infected cats shed viruses and bacteria in ocular discharge, nasal secretions, saliva, and aerosolized droplets during sneezing [1, 4].

Aerosol transmission occurs over short distances, typically within one to two meters, as large droplet nuclei settle rapidly [2, 4]. Fomite transmission is particularly important for FCV, which can survive on contaminated surfaces such as food bowls, bedding, litter boxes, and human hands for several days to weeks depending on environmental conditions [1, 2]. FHV 1 is more labile and inactivates within hours on dry surfaces, but remains viable for longer periods in moist organic material [1, 4].

Vertical transmission from queen to kitten occurs postpartum via infected maternal secretions, and kittens may become infected during the first few weeks of life [2, 3]. Stress factors such as overcrowding, poor ventilation, malnutrition, and concurrent illness significantly increase the risk of transmission within populations [1, 2].

Clinical Signs

The clinical presentation of feline respiratory infections ranges from subclinical carrier states to severe respiratory distress. The typical incubation period is two to ten days depending on the pathogen and inoculum size [1, 4].

Upper Respiratory Tract Signs

Sneezing, nasal congestion, serous to mucopurulent nasal discharge, and conjunctivitis are hallmark signs of FRI [1, 2]. FHV 1 is classically associated with severe conjunctivitis, chemosis, and corneal ulceration (dendritic ulcers) [2, 4]. FCV often presents with oral ulceration on the tongue, hard palate, and lips, which can cause hypersalivation and anorexia [1, 2]. C. felis infection produces predominantly ocular signs: bilateral serous conjunctivitis that progresses to mucopurulent discharge and conjunctival hyperemia [3, 5]. B. bronchiseptica infection frequently includes a prominent cough, which is less common in viral infections, along with pyrexia and lethargy [3, 6].

Lower Respiratory Tract Signs

In severe cases, especially in kittens and immunocompromised cats, infection can descend to the lower respiratory tract producing pneumonia, dyspnea, tachypnea, and productive cough [2, 6]. Auscultation may reveal crackles or wheezes, and radiographic imaging can demonstrate interstitial or alveolar patterns [2, 6].

Systemic Signs

Lethargy, pyrexia, and anorexia are common systemic signs resulting from inflammatory cytokine release [1, 2]. Dehydration can develop secondary to reduced water intake due to nasal obstruction or oral pain [2, 4]. In virulent systemic FCV infection, additional signs include subcutaneous edema, cutaneous ulceration, jaundice, and multi-organ failure, with mortality rates exceeding 50 percent in affected outbreaks [2, 4].

Are Cat Respiratory Infections Dangerous?

The answer to the question "are cat respiratory infections dangerous" depends on the pathogen, host immune status, and environmental factors. In otherwise healthy adult cats, FRI is often self-limiting with supportive care alone, and clinical signs resolve within seven to fourteen days [1, 2]. However, kittens, geriatric cats, and immunosuppressed individuals are at high risk for severe complications including chronic rhinosinusitis, aspiration pneumonia, ulcerative keratitis, and even death [1, 2, 4]. FHV 1 infection can lead to corneal scarring and symblepharon formation if corneal ulceration is not managed aggressively [2, 4]. Persistent viral shedding and recurrent reactivation episodes make FRI a chronic management challenge in multi-cat populations [1, 4].

Diagnostic Approach

Diagnosis of FRI relies on a combination of clinical examination, cytology, molecular assays, and serology. Because clinical signs overlap significantly among pathogens, definitive identification of the causative agent often requires laboratory confirmation [2, 3].

Polymerase chain reaction (PCR) assays are the gold standard for detecting FHV 1, FCV, B. bronchiseptica, C. felis, and M. felis from conjunctival or nasal swabs [2, 3, 5]. Quantitative PCR can provide additional information about viral load, although the clinical utility of viral load quantification remains under investigation [2, 4]. Immunofluorescence assays and enzyme-linked immunosorbent assays (ELISAs) are also used for antigen detection, particularly for C. felis and C. felis [3, 5].

Bacterial culture and susceptibility testing is indicated when B. bronchiseptica or other secondary bacterial infections are suspected, especially in cases that fail to respond to empirical therapy [3, 6]. Cytological examination of conjunctival scrapings or nasal exudate may reveal neutrophilic infiltration, intracellular bacteria (C. felis inclusion bodies), or eosinophilic inflammation suggestive of other etiologies [3, 5].

flowchart TD
    A[Cat presents with respiratory signs], > B{Clinical examination}
    B, > C[Ocular discharge? Sneezing? Cough? Oral ulcers?]
    C, > D[Collect conjunctival and nasal swabs]
    D, > E{Laboratory testing}
    E, > F[PCR panel: FHV-1, FCV, Bordetella, Chlamydia, Mycoplasma]
    E, > G[If cough prominent: bacterial culture]
    E, > H[If ocular lesions: cytology for inclusion bodies]
    F, > I[Identify primary pathogen(s)]
    G, > I
    H, > I
    I, > J[Select targeted therapy: antivirals, antibiotics, supportive care]
    J, > K[Monitor response and adjust treatment]

Treatment

There is no specific antiviral therapy approved for FHV 1 or FCV infection in cats; treatment is primarily supportive [1, 2]. Supportive care includes nutritional support, fluid therapy, humidification, and placement in a stress free environment [1, 2]. Topical ophthalmic antivirals such as famciclovir (systemic), cidofovir, or trifluridine may reduce viral replication in herpetic keratitis [2, 4]. Broad-spectrum antibiotics are indicated when secondary bacterial infection is confirmed or strongly suspected, with doxycycline being a first-line choice for Chlamydia felis and Mycoplasma felis [3, 5]. Azithromycin and enrofloxacin are alternatives, although resistance in B. bronchiseptica has been reported [3, 6].

Symptomatic therapy includes mucolytic agents (e.g., bromhexine), nebulization with saline, and application of ophthalmic lubricants for keratitis [2, 4]. Corticosteroids are contraindicated in acute FHV 1 infection due to the risk of viral reactivation and corneal perforation [2, 4].

Zoonotic Potential: Is Cat Respiratory Infection Contagious to Humans?

The question "is cat respiratory infection contagious to humans" requires a careful species specific analysis. Most feline respiratory pathogens exhibit strong host specificity and are not considered zoonotic [1, 3]. FHV 1 and FCV are strictly feline pathogens and pose no known risk to humans [1, 4].

However, Bordetella bronchiseptica is a notable exception. This bacterium can cause respiratory infection in immunocompromised humans, particularly those with HIV/AIDS, organ transplant recipients, or individuals receiving immunosuppressive therapy [3, 6]. Zoonotic transmission from cats to humans has been documented in several case reports, although it remains rare [3, 6]. The primary route is direct contact with respiratory secretions or aerosols from infected cats [3, 6].

Chlamydia felis has been isolated from humans with conjunctivitis, particularly in individuals with close contact to infected cats, but the zoonotic risk is considered low [3, 5]. Mycoplasma felis has not been convincingly demonstrated to cause disease in humans [3, 6].

Immunocompromised individuals should be counseled about the potential risks of exposure to cats with acute respiratory infections, and strict hygiene practices (hand washing, avoiding contact with ocular/nasal discharge) should be recommended [3, 6].

Prevention

Prevention of feline respiratory infections relies on vaccination, biosecurity, and environmental management.

Vaccination: Core vaccines for cats include modified-live or inactivated formulations for FHV 1 and FCV [1, 2]. Vaccination reduces the severity of clinical disease but does not prevent infection or shedding [1, 2]. A non-core vaccine for B. bronchiseptica is available and recommended for cats with high exposure risk (shelter, boarding, multi-cat households) [3, 6]. A vaccine for C. felis is also available in some regions [3, 5].

Biosecurity: In multi-cat environments, quarantine of new arrivals for at least two weeks, isolation of symptomatic cats, and rigorous cleaning of shared surfaces with disinfectants effective against non-enveloped viruses (e.g., accelerated hydrogen peroxide, sodium hypochlorite, or potassium peroxymonosulfate) are critical [1, 2, 4]. Hand hygiene between handling cats reduces fomite transmission [1, 2].

Environmental factors: Adequate ventilation, reduced stocking density, and minimizing stress through environmental enrichment can decrease the incidence of outbreaks [1, 2]. Routine screening of new additions for FHV 1 and FCV using PCR is recommended in catteries and shelters [2, 4].

Conclusions

Feline respiratory infections represent a multifactorial disease complex in which viral pathogens initiate epithelial damage and bacterial agents contribute to secondary inflammation and suppuration. Transmission occurs primarily through direct contact and fomites, with kittens and immunocompromised adults at greatest risk for severe disease. While most feline respiratory pathogens are host restricted, Bordetella bronchiseptica carries a low zoonotic risk for immunosuppressed humans. Effective prevention combines vaccination, biosecurity protocols, and environmental management to reduce pathogen circulation in feline populations.

References

[1] Merck Veterinary Manual. Feline Respiratory Disease Complex. Kenilworth, NJ: Merck & Co., Inc. (Standard textbook reference.)

[2] Sykes JE. Feline Upper Respiratory Tract Infections. In: Sykes JE, Greene CE, eds. Infectious Diseases of the Dog and Cat. 5th ed. Elsevier; (Standard textbook reference.)

[3] Lappin MR. Bacterial Causes of Feline Upper Respiratory Tract Infections. In: August JR, ed. Consultations in Feline Internal Medicine. 7th ed. Elsevier; (Standard textbook reference.)

[4] Gaskell RM, Dawson S. Feline Herpesvirus and Feline Calicivirus. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. Saunders; (Standard textbook reference.)

[5] Gruffydd-Jones T, Addie D, Belak S, et al. Chlamydophila felis Infection. ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery. (Guideline document; no specific authors required for generic referencing.)

[6] Welsh RD. Bordetella bronchiseptica Infections in Small Animals. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. Saunders; (Standard textbook reference.) *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.